Alexandria Real Estate Equities, Inc. Refreshes and Extends Its $500 Million Common Stock Repurchase Program
Rhea-AI Summary
Alexandria Real Estate Equities (NYSE: ARE) announced that its Board authorized a refreshed common stock repurchase program of up to $500 million, replacing the prior authorization that was set to expire December 31, 2025.
Under the prior program the company repurchased $258.2 million of common stock, primarily in January 2025. The new authorization permits purchases in the open market or by negotiated transactions, accelerated share repurchases, indirect purchases including derivatives, or other transactions through December 31, 2026. Repurchases are discretionary, may be suspended, and will depend on price, available capital, market and economic conditions. The company said its preference is to fund repurchases on a leverage-neutral basis using operating cash after dividends and proceeds from property dispositions or joint ventures.
Positive
- Board authorized up to $500M repurchase through Dec 31, 2026
- Prior program repurchases totalled $258.2M (primarily Jan 2025)
- Company preference to fund repurchases on a leverage-neutral basis
Negative
- Repurchases are discretionary and not guaranteed; program may be suspended
- Program allows derivatives and negotiated transactions, adding execution complexity
Key Figures
Market Reality Check
Peers on Argus
ARE fell 2.38% with elevated volume, while key office REIT peers like BXP, VNO, CUZ, and SLG were also down between about 1.8% and 2.78%, suggesting pressure across office REITs even as ARE announced a refreshed buyback.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Dividend change | Negative | -10.1% | Q4 2025 dividend cut by 45% to preserve about $410M liquidity. |
| Oct 27 | Earnings update | Neutral | +0.6% | Reported Q3 2025 net loss but solid adjusted FFO and occupancy metrics. |
| Oct 22 | Award & partnership | Positive | +1.3% | Recognition for MAP-D precision medicine partnership targeting Phase 1 launch. |
| Sep 26 | Strategic partnership | Positive | -0.4% | Opened Lilly Gateway Labs San Diego at Torrey Pines megacampus. |
| Sep 04 | Reputation & leasing | Positive | +1.6% | Named among most trustworthy firms and secured largest life science lease. |
Recent news has often led to aligned price moves, with negative balance-sheet actions (like dividend cuts) drawing sharper selloffs than strategic or reputational positives.
Over the last few months, Alexandria has reported sizeable non-cash-driven net losses, maintained strong liquidity, and announced substantial leasing and partnership activity. A sharp 45% dividend cut in early Dec 2025 prompted a -10.05% reaction, underscoring investor sensitivity to capital allocation. Earlier, a $500 million repurchase authorization in Dec 2024 coincided with a positive move. Today’s refreshed $500 million buyback extends that capital-return framework into Dec 31, 2026 against a weaker share price backdrop.
Market Pulse Summary
This announcement refreshes Alexandria’s capital return framework, replacing the prior $500 million authorization with a new $500 million repurchase program running through December 31, 2026. It follows a recent 45% dividend reduction intended to preserve about $410 million of annual liquidity and earlier common stock buybacks of $258.2 million. Investors may focus on execution of repurchases, funding via operations and asset sales, and how these choices interact with recent earnings headwinds.
Key Terms
derivatives financial
joint ventures financial
leverage-neutral financial
AI-generated analysis. Not financial advice.
The specific timing, price, and amount of any repurchases will be determined by the Company in its discretion and will depend on a variety of factors, including prevailing stock prices, available capital, general economic and market conditions, and other considerations. The stock repurchase program does not obligate the Company to repurchase any dollar amount or number of shares of Common Stock and may be suspended or discontinued at any time. The Company's preference is to fund stock repurchases, if any, through December 31, 2026 on a leverage-neutral basis with net cash provided by operating activities after dividends and proceeds from real estate dispositions and/or joint ventures.
About Alexandria Real Estate Equities, Inc.
Alexandria, an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative MegacampusTM ecosystems in AAA life science innovation cluster locations, including
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding the Company's stock repurchase program. These forward-looking statements are based on the Company's present intent, beliefs, or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Actual results may differ materially from those contained in or implied by the Company's forward-looking statements as a result of a variety of factors, including, without limitation, the risks and uncertainties detailed in its filings with the Securities and Exchange Commission. All forward-looking statements are made as of the date of this press release, and the Company assumes no obligation to update this information. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in the Company's forward-looking statements, and risks and uncertainties to the Company's business in general, please refer to the Company's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and any subsequently filed quarterly reports on Form 10-Q.
CONTACT: Joel S. Marcus, Executive Chairman & Founder, (626) 578-9693, jmarcus@are.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-refreshes-and-extends-its-500-million-common-stock-repurchase-program-302634413.html
SOURCE Alexandria Real Estate Equities, Inc.